Senior Director of Biostatistics, TESARO
Dr. Guo earned MS in Biostatistics from University of Massachusetts, Amherst and a PhD in Biostatistics from Boston University. Prior to joining TESARO, she worked at the Harvard School of Public Health, Harvard Clinical Research Institute, Synta Pharmaceuticals, and EMD Serono. She has extensive experience in developing medicines in Immuno-Oncology including dostarlimab (TESARO) , avelumab (EMD Serono) and TGF-β TRAP (EMD Serono) as well as small molecules such as ZEJULA (TESARO) and Ganetespib (Synta).